Suppr超能文献

解析m5C修饰在癌症中对RNA的重要作用及机制。

Deciphering the vital roles and mechanism of m5C modification on RNA in cancers.

作者信息

Zheng Lemei, Duan Yumei, Li Mengna, Wei Jianxia, Xue Changning, Chen Shipeng, Wei Qingqing, Tang Faqing, Xiong Wei, Zhou Ming, Deng Hongyu

机构信息

NHC Key Laboratory of Carcinogenesis, Hunan Key Laboratory of Oncotarget Gene, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University Changsha, Hunan, China.

Cancer Research Institute and School of Basic Medical Sciences, Central South University Changsha, Hunan, China.

出版信息

Am J Cancer Res. 2023 Dec 15;13(12):6125-6146. eCollection 2023.

Abstract

5-methylcytosine (m5C modification) plays an essential role in tumors, which affects different types of RNA, the expression of downstream target genes, and downstream pathways, thus participating in the tumor process. However, the effect of m5C modification on RNA in tumors and the exact mechanism have not been systematically reviewed. Therefore, we reviewed the status and sites of m5C modification, as well as the expression pattern and biological functions of m5C regulators in tumors, and further summarized the effects and regulation mechanism of m5C modification on messenger RNA (mRNA), ribosomal RNA (rRNA), transfer RNA (tRNA), long non-coding RNA (lncRNA) and other RNA in tumors. Finally, we summed up the interaction network, potential application, and value in clinical diagnosis and treatment of tumors. Taken together, this review benefits revealing the mechanism of m5C modification in tumor progression and provides new strategies for tumor diagnosis and treatment.

摘要

5-甲基胞嘧啶(m5C修饰)在肿瘤中发挥着重要作用,它影响不同类型的RNA、下游靶基因的表达以及下游通路,从而参与肿瘤进程。然而,m5C修饰对肿瘤中RNA的影响及确切机制尚未得到系统综述。因此,我们综述了m5C修饰的状态和位点,以及m5C调节剂在肿瘤中的表达模式和生物学功能,并进一步总结了m5C修饰对肿瘤中信使核糖核酸(mRNA)、核糖体核糖核酸(rRNA)、转运核糖核酸(tRNA)、长链非编码核糖核酸(lncRNA)和其他RNA的影响及调控机制。最后,我们总结了其相互作用网络、潜在应用以及在肿瘤临床诊断和治疗中的价值。综上所述,本综述有助于揭示m5C修饰在肿瘤进展中的机制,并为肿瘤诊断和治疗提供新策略。

相似文献

1
Deciphering the vital roles and mechanism of m5C modification on RNA in cancers.
Am J Cancer Res. 2023 Dec 15;13(12):6125-6146. eCollection 2023.
2
RNA 5-Methylcytosine Modification: Regulatory Molecules, Biological Functions, and Human Diseases.
Genomics Proteomics Bioinformatics. 2024 Dec 3;22(5). doi: 10.1093/gpbjnl/qzae063.
3
Novel insights into the role of 5-Methylcytosine RNA methylation in human abdominal aortic aneurysm.
Front Biosci (Landmark Ed). 2021 Nov 30;26(11):1147-1165. doi: 10.52586/5016.
4
Overall Survival Signature of 5-Methylcytosine Regulators Related Long Non-Coding RNA in Hepatocellular Carcinoma.
Front Oncol. 2022 May 24;12:884377. doi: 10.3389/fonc.2022.884377. eCollection 2022.
5
Transcriptome-Wide 5-Methylcytosine Functional Profiling of Long Non-Coding RNA in Hepatocellular Carcinoma.
Cancer Manag Res. 2020 Aug 4;12:6877-6885. doi: 10.2147/CMAR.S262450. eCollection 2020.
10
Eukaryotic rRNA Modification by Yeast 5-Methylcytosine-Methyltransferases and Human Proliferation-Associated Antigen p120.
PLoS One. 2015 Jul 21;10(7):e0133321. doi: 10.1371/journal.pone.0133321. eCollection 2015.

引用本文的文献

3
The role of m5C, m1A and m7G modifications in tumors of urinary system.
Front Cell Dev Biol. 2025 Jul 30;13:1549588. doi: 10.3389/fcell.2025.1549588. eCollection 2025.
5
Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance.
Signal Transduct Target Ther. 2025 Jul 18;10(1):219. doi: 10.1038/s41392-025-02266-z.
6
Construction of a risk model based on m5C-associated lncRNAs to predict the prognosis in renal cell carcinoma.
Medicine (Baltimore). 2025 Jul 4;104(27):e43052. doi: 10.1097/MD.0000000000043052.
9
The multifaceted role of m5C RNA methylation in digestive system tumorigenesis.
Front Cell Dev Biol. 2025 Mar 6;13:1533148. doi: 10.3389/fcell.2025.1533148. eCollection 2025.

本文引用的文献

4
Function of mC RNA methyltransferase NOP2 in high-grade serous ovarian cancer.
Cancer Biol Ther. 2023 Dec 31;24(1):2263921. doi: 10.1080/15384047.2023.2263921. Epub 2023 Oct 6.
5
NOP2/Sun RNA methyltransferase 2 is a potential pan-cancer prognostic biomarker and is related to immunity.
PLoS One. 2023 Sep 28;18(9):e0292212. doi: 10.1371/journal.pone.0292212. eCollection 2023.
6
NSUN2 is a glucose sensor suppressing cGAS/STING to maintain tumorigenesis and immunotherapy resistance.
Cell Metab. 2023 Oct 3;35(10):1782-1798.e8. doi: 10.1016/j.cmet.2023.07.009. Epub 2023 Aug 15.
8
NOP2-mediated m5C methylation of XPD is associated with hepatocellular carcinoma progression.
Neoplasma. 2023 Jun;70(3):340-349. doi: 10.4149/neo_2023_230110N17.
9
NSUN2 stimulates tumor progression via enhancing TIAM2 mRNA stability in pancreatic cancer.
Cell Death Discov. 2023 Jul 1;9(1):219. doi: 10.1038/s41420-023-01521-y.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验